MO-ASM-GLOBAL
Bass Pro Shops Big Cedar Lodge announced today that on July 21 the Ozarks will rock as the ancient hills, valleys and lakes never have when the world’s greatest rock-and-roll band, The Rolling Stones, light up Thunder Ridge Nature Arena for the last performance on their final North American tour.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240523211894/en/
Rendering of Thunder Ridge Nature Arena (Graphic: Business Wire)
The concert promises to be one of the most memorable and highly anticipated concert events ever. It is a pairing of the World’s Greatest Rock-and-Roll Band and the most breathtaking and awe-inspiring outdoor amphitheater in all of North America.
The Thunder Ridge concert stop is part of the “Hackney Diamonds Tour ’24” for The Rolling Stones, which includes 20 performances in 16 cities. Tickets will go on sale Friday, May 31, and will be available at ThunderRidgeNatureArena.com.
“We’re honored to host The Rolling Stones at Thunder Ridge Nature Arena and to showcase the amazing beauty of the Ozarks to music fans of all generations,” said Johnny Morris, visionary conservationist and founder of Bass Pro Shops. “The Stones are the most iconic rock-and-roll band ever, and we know they will put on a remarkable show that no one will ever forget! Their appearance will become a part of the history of this beautiful mountain in the Ozarks.”
Thunder Ridge is a world-class destination admired by legends of rock.
Representatives from The Rolling Stones scouted Thunder Ridge by attending the sold-out Garth Brooks concert in September 2022. After attending the show, the advance team reported back that Thunder Ridge was one of the most extraordinary and beautiful event venues they had ever seen.
A legendary night of entertainment began on a fishing trip with two of the leading conservationists of our time.
A partnership between The Rolling Stones, the Ozarks and Johnny Morris is something few would have expected; but, in fact, this is a relationship decades in the making. More than 20 years ago, the Stones renowned keyboard and piano player, Chuck Leavell, joined Johnny Morris to celebrate the opening of a Bass Pro Shops near Chuck’s home in Macon, Georgia. Out of this shared experience, Johnny and Chuck developed a special friendship founded on conservation, a love of the outdoors and a few remarkable shared fishing adventures. And now their adventure continues with a concert unlike anything that has ever been seen in the Ozarks.
A noted conservationist, Chuck Leavell is one of only three recipients of an Honorary Forest Ranger award from the U.S. Forest Service and is also a past recipient of the National Outstanding Tree Farmer award. Johnny Morris, is also a legend in conservation and is a recipient of the prestigious Audubon Medal, considered by many to be the highest award in conservation. In the 114-year history of Audubon there have been only 57 recipients for this prestigious award.
Awe-inspiring, nature-based entertainment venue.
The Rolling Stones concert at Thunder Ridge Nature Arena underscores Johnny’s commitment to create one of the finest outdoor entertainment venues in North America and shares the beauty of his beloved Ozarks with others for generations to come. It’s more than just a place for spectacular concerts, rodeos and conventions. The property has been placed in a not-for-profit foundation, and all proceeds from events at the arena will go to further enhance the facilities and support conservation.
Located on about 1,200 acres near Ridgedale, Thunder Ridge is adjacent to the Bass Pro Shops Big Cedar Lodge on land originally purchased by Johnny Morris about 30 years ago. For the past decade, it has accommodated large gatherings, including concerts by Garth Brooks, Hank Williams Jr., Chris Janson, Dierks Bentley, Tracy Lawrence and other major acts.
It also has hosted air shows, hot air balloon shows, the U.S. Open Bowfishing Championship, the U.S. Open National Bass Tournament, the National 4-H Youth Council, rodeos, conventions, symposiums and special events and is set to host nature-based activities for all ages and interests for years to come.
Thunder Ridge is the latest jewel in Big Cedar Lodge’s proud tradition of hosting world-class hospitality and entertainment experiences that span a variety of recreational markets.
The vision for the future is to continue to host a wide variety of world-class outdoor events. The Rolling Stones performance is only the latest in a summer full of marquee concerts already announced for Thunder Ridge. This lineup includes:
- May 25 – Morgan Wallen
- June 13 – Chris Stapleton
- June 15 – Fuerza Regida
- July 21 – The Rolling Stones
- July 27 – Luke Bryan
- Aug. 31 – Slightly Stoopid & Dirty Heads w / HIRIE
- Sept. 8 – Imagine Dragons
- Sept. 21 – Pitbull
More than six decades of rock-and-roll royalty.
Over the last 60 years, The Rolling Stones have defined the rock-and-roll movement, led by vocalist Mick Jagger and guitarist Keith Richards. The group has estimated album sales of 250 million, making them one of the best-selling musical artists of all time.
The Stones have released 30 studio albums, 23 live albums and 12 official compilation albums; and CNN has called them “far and away the most successful act in rock today.” The Grammy Award-winning band was inducted into the Rock & Roll Hall of Fame in 1989 and the U.K. Music Hall of Fame in 2004 and have been ranked by music-industry watchdogs Billboard magazine and Rolling Stone magazine as one of the greatest bands of all time.
This tour is in support of their widely heralded Hackney Diamonds album release from 2022, which received rave reviews from fans and music critics everywhere.
About Thunder Ridge Nature Arena
Thunder Ridge Nature Arena is a breathtaking outdoor amphitheater nestled in the heart of the Ozarks in Ridgedale, Missouri, just a few miles south of Branson. Situated on over 1,200 acres of land dedicated to conservation, the venue offers stunning views of Table Rock Lake and the Boston Mountains of Arkansas. Thunder Ridge Nature Arena is part of the Johnny Morris Conservation Foundation, dedicated to preserving and celebrating the natural beauty of the Ozarks. All venue proceeds go directly to conservation efforts to protect the land, wildlife and natural habitats of the Ozark region.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240523211894/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom